tamsulosin has been researched along with Urethral Obstruction in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Alshammari, D; Brownrigg, N; Chua, ME; D'Souza, N; Dos Santos, J; Khondker, A; Kim, JK; Lorenzo, AJ; Richter, J; Rickard, M; Tasian, G; Weaver, J | 1 |
| Hou, Y; Liu, N; Ren, H; Shang, W; Yin, Z; Zuo, S | 1 |
| Hakozaki, A; Miyoshi, K; Noma, T; Orimoto, N; Sasaki, E; Tsukihara, H; Yoshida, S | 1 |
| Alyaev, YG; Demidko, YL; Fiev, DN; Glybochko, PV; Kopylov, PY; Rapoport, LM; Syrkin, AL; Tsarichenko, DG; Vinarov, AZ | 1 |
| Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Yamamoto, H | 1 |
| Kawabe, K | 1 |
| Kobayashi, K; Kobayashi, M; Kobayashi, S; Maezawa, A; Maruyama, I; Shibata, N; Tatemichi, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Claes, H; De Reijke, TM; Folkestad, B; Höfner, K; Speakman, MJ | 1 |
| Akino, H; Arai, Y; Fukuyama, T; Hida, S; Okabe, T; Okada, K; Takeuchi, H; Tomoyoshi, T; Yoshida, O | 1 |
3 review(s) available for tamsulosin and Urethral Obstruction
| Article | Year |
|---|---|
Assessing the Utility of Tamsulosin in Delaying Progression to Clean Intermittent Catheterization and End-stage Renal Disease in Patients With Posterior Urethral Valves: Are We Postponing the Inevitable?
Topics: Cholinergic Antagonists; Humans; Intermittent Urethral Catheterization; Kidney Failure, Chronic; Prospective Studies; Retrospective Studies; Tamsulosin; Urethral Obstruction; Urinary Bladder | 2023 |
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Cloning, Molecular; Drug Design; Drug Tolerance; Humans; Male; Molecular Sequence Data; Naphthalenes; Piperazines; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethral Obstruction | 2006 |
[Latest frontiers in pharmacotherapy for benign prostatic hyperplasia].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Design; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethral Obstruction | 2006 |
2 trial(s) available for tamsulosin and Urethral Obstruction
| Article | Year |
|---|---|
Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Incidence; Libido; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Obstruction | 1999 |
[Clinical efficacy and safety of long-term administration of YM617 for urinary obstruction of the lower urinary tract].
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Evaluation; Female; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethral Obstruction; Urinary Bladder Neck Obstruction | 1991 |
4 other study(ies) available for tamsulosin and Urethral Obstruction
| Article | Year |
|---|---|
Inhibition of α1-adrenoceptor reduces TGF-β1-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Male; Mice; Mice, Inbred C57BL; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Receptors, Adrenergic, alpha-1; Renal Insufficiency, Chronic; Smad3 Protein; Tamsulosin; Transforming Growth Factor beta; Urethral Obstruction | 2020 |
Therapeutic effect of TAC-302, a cyclohexenoic fatty alcohol derivative, on bladder denervation-related storage and voiding dysfunctions in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Cyclohexenes; Denervation; Fatty Alcohols; Female; Immunohistochemistry; Muscle Contraction; Rats; Rats, Sprague-Dawley; Tamsulosin; Urethral Obstruction; Urinary Bladder; Urinary Bladder Neck Obstruction; Urination; Urodynamics; Urological Agents | 2018 |
Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Electrocardiography, Ambulatory; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Myocardial Ischemia; Prostatic Hyperplasia; Russia; Tamsulosin; Urethral Obstruction; Urological Agents | 2019 |
Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Carotid Artery, Common; Data Interpretation, Statistical; Dogs; Electric Stimulation; Heart Rate; Hypogastric Plexus; In Vitro Techniques; Indoles; Male; Naphthalenes; Norepinephrine; Organ Specificity; Piperazines; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra; Urethral Obstruction; Urinary Tract | 2006 |